The American Association for Cancer Research has named the 2020-2021 inaugural class of FDA-AACR Oncology Educational Fellows.
Alliance Cancer Specialists and Northwest Oncology have joined the US Oncology Network.
The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) and the Ohio State College of Pharmacy have been awarded a five-year, $7 million competitive Program Project grant renewal from NCI.
The Walther Cancer Foundation plans to invest $11 million to advance collaborative cancer research at Indiana University and Purdue University by supporting scientists through bioinformatics.
John Glaspy was named the inaugural Simms/Mann Family Foundation Endowed Chair in Integrative Oncology at David Geffen School of Medicine at University of California, Los Angeles.
The Sidney Kimmel Cancer Center–Jefferson Health and Thomas Jefferson University has said its cancer research programs will be clustered into four key areas: Cancer Risk and Control; Molecular Oncology Regulation and Approaches; Translational and Cellular Oncology; and Immune Cell Regulation and Targeting.
Kelvin Lee was named director of the Indiana University Melvin and Bren Simon Comprehensive Cancer Center.
Jan Kitajewski was named director of the University of Illinois Cancer Center, effective Oct. 16, 2020.
Ira Pastan, distinguished investigator at NCI, has received the Paul A. Volcker Career Achievement Medal from the Partnership for Public Service for his discovery of moxetumomab pasudotox-tdfk (Lumoxiti), which is indicated for the treatment of relapsed or refractory hairy cell leukemia.
Thomas J. Fuchs was named co-director of the Hasso Plattner Institute for Digital Health at Mount Sinai, dean of artificial intelligence and human health, and professor of computational pathology and computer science in the Department of Pathology at the Icahn School of Medicine at Mount Sinai.
